EP3232199
COMBINATION OF IMMUNOSUPPRESSIVE FACTOR BLOCKING AGENT AND BIGUANIDE ANTIDIABETIC DRUG FOR USE IN A METHOD OF PREVENTING PROGRESSION OF, TREATING AND/OR PREVENTING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.8.2015EP published:
4.5.2022EP application number:
17174222.4
EPO information:
European Patent Register
Max expiry date:
16.8.2035
Title in English:
COMBINATION OF IMMUNOSUPPRESSIVE FACTOR BLOCKING AGENT AND BIGUANIDE ANTIDIABETIC DRUG FOR USE IN A METHOD OF PREVENTING PROGRESSION OF, TREATING AND/OR PREVENTING CANCERLanguage of the patent:
English
Timeline
Today
17.8.2015EP application
4.5.2022EP Publication
Owner
Name:
National University Corporation Okayama UniversityAddress:
1-1, Tsushima-naka 1-chome, Kita-ku Okayama-shi Okayama 700-8530, JP
Name:
ONO PHARMACEUTICAL CO., LTD.Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, JP
Inventor
Name:
UDONO, HeiichiroAddress:
Okayama 700-8530, JP
Name:
EIKAWA, ShingoAddress:
Okayama 700-8530, JP
Name:
TOYOOKA, Shin-ichiAddress:
Okayama 700-8530, JP
Priority
Number:
2014166593Date:
19.8.2014Country:
JP
Number:
2015085556Date:
20.4.2015Country:
JP
Classification
Categories:
G01N 33/574, G01N 33/564, G01N 33/569